IDEAYA Biosciences
(NASDAQ) IDYA
IDEAYA Biosciences Financials at a Glance
Market Cap
$2.72B
Revenue (TTM)
$218.71M
Net Income (TTM)
$113.70M
EPS (TTM)
$-1.30
P/E Ratio
-23.79
Dividend
$0.00
Beta (Volatility)
1.07 (Average)
Dividend
$0.00
Beta (Volatility)
1.07 (Average)
Price
$31.04
Volume
66,120
Open
$30.64
Price
$31.04
Volume
66,120
Open
$30.64
Previous Close
$31.04
Daily Range
$30.64 - $31.52
52-Week Range
$15.33 - $39.28
Dividend
$0.00
Beta (Volatility)
1.07 (Average)
Price
$31.04
Volume
66,120
Open
$30.64
Previous Close
$31.04
Daily Range
$30.64 - $31.52
52-Week Range
$15.33 - $39.28
IDYA News
IDYA: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout IDEAYA Biosciences
Industry
Biotechnology
Sector
Health CareEmployees
145
CEO
Yujiro S. Hata, MBA
Website
www.ideayabio.comHeadquarters
South San Francisco, CA 94080, US
IDYA Financials
Key Financial Metrics (TTM)
Gross Margin
98%
Operating Margin
-73%
Net Income Margin
-52%
Return on Equity
-11%
Return on Capital
-15%
Return on Assets
-10%
Earnings Yield
-4.20%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$2.72B
Shares Outstanding
87.81M
Volume
66.12K
Short Interest
0.00%
Avg. Volume
919.91K
Financials (TTM)
Gross Profit
$214.12M
Operating Income
$159.31M
EBITDA
$154.72M
Operating Cash Flow
$71.10M
Capital Expenditure
$2.37M
Free Cash Flow
$73.47M
Cash & ST Invst.
$639.39M
Total Debt
$27.91M
IDEAYA Biosciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$10.88M
+55.4%
Gross Profit
$9.68M
+52.3%
Gross Margin
88.99%
N/A
Market Cap
$2.72B
N/A
Market Cap/Employee
$20.78M
N/A
Employees
131
N/A
Net Income
$83.27M
+36.1%
EBITDA
$93.37M
+28.0%
Quarterly Fundamentals
Net Cash
$583.90M
-11.1%
Accounts Receivable
$5.97M
+199000.0%
Inventory
$0.00
N/A
Long Term Debt
$55.15M
+192.2%
Short Term Debt
$339.00K
+13.8%
Return on Assets
-10.25%
N/A
Return on Invested Capital
-15.17%
N/A
Free Cash Flow
$90.83M
+26.0%
Operating Cash Flow
$90.50M
+25.6%